Penetration of piperacillin/tazobactam into cancellous and cortical bone tissue

Current Therapeutic Research - Clinical and Experimental

Volumn 62, Issue 7, 2001, Pages 538-545

  Boselli, Emmanuel ^a   Breilh, Dominique ^b   Biot, Loic ^c   Bel, Jean Christophe ^c   Saux, Marie Claude ^b   Allaouchiche, Bernard ^a  

^a HÔTEL DIEU   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Antibiotics; Bone; Diffusion; Piperacillin tazobactam

Indexed keywords

PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ARTICLE; BONE INFECTION; CANCELLOUS BONE; CLINICAL ARTICLE; CORTICAL BONE; CREATININE CLEARANCE; DRUG DIFFUSION; DRUG EFFICACY; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INFECTIOUS ARTHRITIS; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0034922136     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(01)80053-9     Document Type: Article

References (9)

1. Diffusion in bone tissue of antibiotics
2. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam
3. Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues
4. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery
5. The inhibitory quotient - A method for interpreting minimum inhibitory concentration data
6. Micro-organisms responsible for osteo-articular infections
7. In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates
8. Piperacillin/tazobactam: A critical review of the evolving clinical literature
9. Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin